Immunogenicity 10382

summary
Sample ID
3812
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
ALG6
Transcript ID
uc010oox.2
HLA INFO
DRB*07:01
TCR INFO

No TCR info found!

T cell Tumor cell DRB*07:01
sequence
Full length protein sequence (254 aa)
MELYH
1
ALPFF
6
CFLLG
11
KCFKK
16
GLKGK
21
GFVLL
26
VKLAC
31
IVVAS
36
FVLCW
41
LPFFT
46
EREQT
51
LQVLR
56
RLFPV
61
DRGLF
66
EDKVA
71
NIWCS
76
FNVFL
81
KIKDI
86
LPRHI
91
QLIMR
96
PVCLV
101
LSEIP
106
FMSTW
111
FLLVS
116
TFSML
121
PLLLK
126
DELLM
131
PSVVT
136
TMAFF
141
IACVT
146
SFSIF
151
EKTSE
156
EELQL
161
KSFSI
166
SVRKY
171
LPCFT
176
FLSRI
181
IQYLF
186
LISVI
191
TMVLL
196
TLMTV
201
TLDPP
206
QKLPD
211
LFSVL
216
VCFVS
221
CLNFL
226
FFLVY
231
FNIII
236
MWDSK
241
SGRNQ
246
KKIS
251
Mutation Information
DNA mutation:
None
Peptide Range:
112 ~ 136
Mut AA position:
124 (13 in Wild Type peptide)
Alignment
Wild Type:
"MSTWFLLVSTFSMLPLLLKDELLMP
||||||||||||.||||||||||||
Mutant:
MSTWFLLVSTFSILPLLLKDELLMP"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) ALG6

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

None

Assay

IFNg ELISPOT assay